Jagiellonian University Repository

4-year experience with percutaneous US-guided radiofrequency ablation of kidney tumors

pcg.skipToMenu

4-year experience with percutaneous US-guided radiofrequency ablation of kidney tumors

Show full item record

dc.contributor.author Salagierska-Barwińska, Anna pl
dc.contributor.author Salagierski, Marek pl
dc.contributor.author Salagierski, Maciej pl
dc.date.accessioned 2019-06-06T08:07:58Z
dc.date.available 2019-06-06T08:07:58Z
dc.date.issued 2007 pl
dc.identifier.issn 1733-134X pl
dc.identifier.uri https://ruj.uj.edu.pl/xmlui/handle/item/76685
dc.language eng pl
dc.rights Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa *
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/pl/legalcode *
dc.title 4-year experience with percutaneous US-guided radiofrequency ablation of kidney tumors pl
dc.type JournalArticle pl
dc.description.physical 32-35 pl
dc.description.additional Bibliogr. s. 35 pl
dc.identifier.weblink http://archiwum.inforadiologia.pl/download/index/idArt/478067.html pl
dc.abstract.en Background: The past decades have significantly changed the diagnosis and management of kidney tumors. There is a growing trend for a less invasive therapeutic approach. The study seeks to present our experience with a number of patients who underwent percutaneous ultrasound (US)-guided radiofrequency ablation (RFA) of renal masses. Material/Methods: From July 2002 to December 2006, RFA was carried out in 55 selected patients with an enhancing kidney tumor on computed tomography (CT). The procedure was performed under conscious sedation. The patients were at risk for surgery or had a remaining kidney. Monopolar Cool-tip Tyco or bipolar Celon Olympus RFA devices under US-guidance (convex 3.5 MHz) were used. Abdominal 3-phase multi-slice computed tomography (MSCT) was performed 3, 6 and 12 months post RFA and once yearly thereafter. Results: At a mean follow up of 25 months (range, 6-53 months), 52 of the 55 tumors showed no contrast enhancement on CT. Three incompletely ablated tumors were successfully treated with the second RFA. There were no major complications in any procedure and intervention was well tolerated. So far we have observed one metastasis to a homolateral adrenal gland which was revealed on MSCT. Conclusions: Percutaneous RFA is a minimally invasive technique which appears to be a promising alternative for patients with small renal tumors. 3-phase MSCT improves the imaging of renal masses, enabling not only optimal treatment planning but also a reliable monitoring of tumor destruction after RFA. pl
dc.subject.en minimally invasive technique pl
dc.subject.en renal tumor pl
dc.subject.en radiofrequency ablation pl
dc.description.volume 72 pl
dc.description.number 2 pl
dc.identifier.eissn 1899-0967 pl
dc.title.journal Polish Journal of Radiology pl
dc.language.container eng pl
dc.date.accession 2019-06-06 pl
dc.subtype Article pl
dc.identifier.articleid 478067 pl
dc.rights.original CC-BY-NC-ND; otwarte czasopismo; ostateczna wersja wydawcy; w momencie opublikowania; 0 pl
dc.identifier.project ROD UJ / OP pl


Files in this item

This item appears in the following Collection(s)

Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa Except where otherwise noted, this item's license is described as Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa